<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Leucocyte migration was studied in vivo using a skin window technique, and in vitro by migration under <z:chebi fb="2" ids="2511">agarose</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>No difference was found between 28 patients with <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA), 10 patients with psoriatic <z:hpo ids='HP_0001369'>arthritis</z:hpo> (PA) and 30 healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>Most patients were under treatment with <z:chebi fb="0" ids="35842">anti-rheumatic drugs</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients treated with <z:chebi fb="2" ids="35475">non-steroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>) had significantly lower values (p less than 0.01) than untreated patients </plain></SENT>
<SENT sid="4" pm="."><plain>In vivo but not in vitro migration decreased during short-term treatment with <z:chebi fb="0" ids="47381">diclofenac</z:chebi> and naproxen, an effect observed both in patients and in healthy individuals </plain></SENT>
<SENT sid="5" pm="."><plain>After pre-incubation of <z:mpath ids='MPATH_458'>normal</z:mpath> polymorphonuclear leucocytes with <z:chebi fb="0" ids="47381">diclofenac</z:chebi>, in vitro migration was diminished only at concentrations of 50 micrograms/ml and above, which are at least 10 times higher than those attained clinically </plain></SENT>
<SENT sid="6" pm="."><plain>The in vivo effect of <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> on leucocyte migration may imply a long-term disease modifying influence in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0003864" disease_type="Disease or Syndrome" abbrv="">arthritides</z:e> </plain></SENT>
</text></document>